Unknown

Dataset Information

0

Gut microbiota-CRAMP axis shapes intestinal barrier function and immune responses in dietary gluten-induced enteropathy


ABSTRACT: In the gut, cathelicidin-related antimicrobial peptide (CRAMP) has been largely described for its anti-infective activities. With an increasing recognition of its immune regulatory effects in extra-intestinal diseases, the role of CRAMP in gluten-induced small intestinal enteropathy celiac disease remains unknown. This study aimed to investigate the unexplored role of CRAMP in celiac disease. By applying a mouse model of gluten-induced enteropathy (GIE) recapitulating small intestinal enteropathy of celiac disease, we observed defective CRAMP production in duodenal epithelium during GIE. CRAMP-deficient mice were susceptible to the development of GIE. Exogenous CRAMP corrected gliadin-triggered epithelial dysfunction and promoted regulatory immune responses at the intestinal mucosa. Additionally, GIE-associated gut dysbiosis with enriched Pseudomonas aeruginosa and production of the protease LasB contributed to defective intestinal CRAMP production. These results highlight microbiota-CRAMP axis in the modulation of barrier function and immune responses in GIE. Hence, modulating CRAMP may represent a therapeutic strategy for celiac disease.

SUBMITTER: Dr. Zhengnan Ren 

PROVIDER: S-SCDT-EMM-2021-14059-T | biostudies-other |

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC8350901 | biostudies-literature
| S-EPMC4328744 | biostudies-literature
| S-EPMC8549243 | biostudies-literature
| S-EPMC6835310 | biostudies-literature
| S-EPMC8715217 | biostudies-literature
| S-EPMC7050124 | biostudies-literature
| S-EPMC6175760 | biostudies-other
| S-EPMC9884693 | biostudies-literature
| S-EPMC6304899 | biostudies-other
| S-EPMC5220306 | biostudies-literature